...
首页> 外文期刊>Nephron >Risk Factors of Nontunneled Noncuffed Hemodialysis Catheter Malfunction
【24h】

Risk Factors of Nontunneled Noncuffed Hemodialysis Catheter Malfunction

机译:非隧道非袖带式血液透析导管功能异常的危险因素

获取原文
获取原文并翻译 | 示例

摘要

Background: The use of noncuffed nontunneled central venous catheters is a widely accepted method of gaining temporary vascular access for hemodialysis. Malfunction and bacteremia are the main factors limiting catheter survival. Methods: We followed up prospectively 73 hemodialysis catheters (HC) (40 internal jugular, 33 femoral) in order to establish factors influencing HC malfunction. HC malfunction was defined as a catheter that was unable to attain and maintain blood flows of at least 150 ml/min. 73 HC were used for a total 1,100 days. Results: HC malfunction occurred in 23 cases (31.51%) during the study period, giving an overall rate of 21 episodes per 1,000 catheter days at risk. An analysis revealed a higher risk of HC malfunction with the catheter-ization of the femoral vein compared to the internal jugular vein (hazard ratio (HR) 6.3; 95% confidence interval (Cl) 5.3-7.3). After correction for confounding factors in multivariate Cox analysis, the site of the catheterization remained a statistically significant predictor of HC malfunction (HR 5.03, 95% Cl 3.83-6.23). After the first week malfunction rate was 42 and 8% for femoral and internal jugular site, respectively (relative risk (RR) for malfunction 5.3 (95% Cl, 2.5-8). After the second and third week, the incidence of malfunction was 51 and 14% for femoral and internal jugular vein, respectively (RR 3.6, 95% Cl 2.2-5.1). Conclusions: Catheterization of the internal jugular vein is associated with longer catheter survival when compared to the femoral vein. Hemodialysis catheters should be placed, if possible, in internal jugular vein to prevent their premature malfunction.
机译:背景:使用无袖带无隧道中心静脉导管是获得血液透析临时血管通路的广泛接受的方法。故障和菌血症是限制导管存活的主要因素。方法:我们前瞻性地随访了73例血液透析导管(HC)(40例颈内动脉,33例股骨),以建立影响HC机能障碍的因素。 HC故障定义为无法获得和维持至少150 ml / min的血流的导管。使用了73 HC,总共使用了1100天。结果:在研究期间,有23例(31.51%)的HC发生机能障碍,每千导管日有21次发作的总发生率。分析显示,与颈内静脉相比,股静脉导管置入术会引起HC故障的风险更高(危险比(HR)6.3; 95%置信区间(Cl)5.3-7.3)。在对多元Cox分析中的混杂因素进行校正后,导管插入部位仍是HC机能障碍的统计学显着预测因子(HR 5.03,95%Cl 3.83-6.23)。第一周后股骨和颈内部位的失效率分别为42%和8%(失误的相对风险(RR)5.3(95%Cl,2.5-8)。股静脉和颈内静脉分别为51%和14%(RR 3.6,95%Cl 2.2-5.1)结论:与股静脉相比,颈内静脉导管置入术与更长的导管生存时间相关,应放置血液透析导管,如果可能,请在颈内静脉内进行预防,以防其过早发生故障。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号